S&P 500 Futures
(0.66%) 4 354.25 points
Dow J Futures
(0.60%) 33 927 points
Nasdaq Futures
(0.92%) 15 004 points
Oil
(0.36%) $91.12
Gas
(-0.72%) $2.91
Gold
(-0.37%) $1 859.20
Silver
(-1.74%) $22.06
Platinum
(1.25%) 918.10
USD/EUR
(-0.07%) 0.945
USD/NOK
(-0.19%) 10.67
USD/GBP
(-0.05%) 0.819
USD/RUB
(1.79%) 98.20
Picture of a house with link to the home page

Realtime updates for N4 Pharma PLC [N4P.L]

Exchange: LSE Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated2 Oct 2023 @ 03:21
Share On:
50% discount on Stockinvest.us - Use code: Podcast

-3.85% £ 0.962

Live Chart Being Loaded With Signals

N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom...

Stats
Today's Volume 510 960
Average Volume 919 847
Market Cap 3.26M
P/E -0.960
ATR14 £0.0180 (1.87%)

N4 Pharma PLC Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

N4 Pharma PLC Financials

Annual 2022
Revenue: £0
Gross Profit: £0 (0.00 %)
EPS: £-0.0055
Q2 2019
Revenue: £0.00
Gross Profit: £0.00 (0.00 %)
EPS: £-0.0022
Q1 2019
Revenue: £0.00
Gross Profit: £0.00 (0.00 %)
EPS: £-0.0022
Q1 2019
Revenue: £0.00
Gross Profit: £0.00 (0.00 %)
EPS: £-0.0022

N4 Pharma PLC Dividends

(Q2/95) 1995-05-22 (Q4/95) 1995-11-06 (Q2/96) 1996-06-03 (Q4/96) 1996-11-04 (Q2/97) 1997-05-19
£16.00
(Paid: 1995-07-01) 		£16.00
(Paid: 1995-12-01) 		£18.00
(Paid: 1996-07-01) 		£17.20
(Paid: 1996-12-02) 		£18.00
(Paid: 1997-07-01)

N4 Pharma PLC

N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.

Estimated
 N4P.L Next Dividend
 (2023-10-23) £18.52 Probabilty 100 %
Quarter Ratio
 N4P.L 0.04 0.00